These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25389276)

  • 1. Drug development and nonclinical to clinical translational databases: past and current efforts.
    Monticello TM
    Toxicol Pathol; 2015 Jan; 43(1):57-61. PubMed ID: 25389276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of clinical risks by analysis of preclinical and clinical adverse events.
    Clark M
    J Biomed Inform; 2015 Apr; 54():167-73. PubMed ID: 25746390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A public-private consortium advances cardiac safety evaluation: achievements of the HESI Cardiac Safety Technical Committee.
    Pierson JB; Berridge BR; Brooks MB; Dreher K; Koerner J; Schultze AE; Sarazan RD; Valentin JP; Vargas HM; Pettit SD
    J Pharmacol Toxicol Methods; 2013; 68(1):7-12. PubMed ID: 23567075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical Development.
    Ivens IA; Achanzar W; Baumann A; Brändli-Baiocco A; Cavagnaro J; Dempster M; Depelchin BO; Rovira AR; Dill-Morton L; Lane JH; Reipert BM; Salcedo T; Schweighardt B; Tsuruda LS; Turecek PL; Sims J
    Toxicol Pathol; 2015 Oct; 43(7):959-83. PubMed ID: 26239651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A HESI consortium approach to assess the human predictive value of non-clinical repolarization assays.
    Trepakova ES; Koerner J; Pettit SD; Valentin JP;
    J Pharmacol Toxicol Methods; 2009; 60(1):45-50. PubMed ID: 19439186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs.
    Piccotti JR; Lebrec HN; Evans E; Herzyk DJ; Hastings KL; Burns-Naas LA; Gourley IS; Wierda D; Kawabata TT
    J Immunotoxicol; 2009 Mar; 6(1):1-10. PubMed ID: 19519157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug safety testing paradigm, current progress and future challenges: an overview.
    Ahuja V; Sharma S
    J Appl Toxicol; 2014 Jun; 34(6):576-94. PubMed ID: 24777877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concordance between nonclinical and phase I clinical cardiovascular assessment from a cross-company data sharing initiative.
    Ewart L; Aylott M; Deurinck M; Engwall M; Gallacher DJ; Geys H; Jarvis P; Ju H; Leishman D; Leong L; McMahon N; Mead A; Milliken P; Suter W; Teisman A; Van Ammel K; Vargas HM; Wallis R; Valentin JP
    Toxicol Sci; 2014 Dec; 142(2):427-35. PubMed ID: 25246669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated and translational nonclinical in vivo cardiovascular risk assessment: gaps and opportunities.
    Berridge BR; Hoffmann P; Turk JR; Sellke F; Gintant G; Hirkaler G; Dreher K; Schultze AE; Walker D; Edmunds N; Halpern W; Falls J; Sanders M; Pettit SD
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):38-46. PubMed ID: 23044254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety, efficacy and regulatory triangle in drug development: Impact for animal models and the use of animals.
    van Meer PJ; Graham ML; Schuurman HJ
    Eur J Pharmacol; 2015 Jul; 759():3-13. PubMed ID: 25818943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products.
    Cavagnaro J; Silva Lima B
    Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies.
    Chapman K; Chivers S; Gliddon D; Mitchell D; Robinson S; Sangster T; Sparrow S; Spooner N; Wilson A
    Drug Discov Today; 2014 May; 19(5):528-32. PubMed ID: 24448068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development.
    Mangipudy R; Burkhardt J; Kadambi VJ
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):439-41. PubMed ID: 25058855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the nonclinical quality and toxicology testing for recombinant biopharmaceuticals produced in mammalian cells.
    Lebrec H; Narayanan P; Nims R
    J Appl Toxicol; 2010 Jul; 30(5):387-96. PubMed ID: 20589744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
    Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
    Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigative safety science as a competitive advantage for Pharma.
    Moggs J; Moulin P; Pognan F; Brees D; Leonard M; Busch S; Cordier A; Heard DJ; Kammüller M; Merz M; Bouchard P; Chibout SD
    Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1071-82. PubMed ID: 22769724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A call for more integrated cardiovascular safety assessment.
    Pettit SD; Berridge B; Sarazan RD
    J Pharmacol Toxicol Methods; 2010; 61(1):1-2. PubMed ID: 19706331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonclinical safety assessment of vaccines and adjuvants.
    Wolf JJ; Kaplanski CV; Lebron JA
    Methods Mol Biol; 2010; 626():29-40. PubMed ID: 20099119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role for microRNAs in drug toxicity and in safety assessment.
    Marrone AK; Beland FA; Pogribny IP
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):601-11. PubMed ID: 25739314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.